Izilendustat (hydrochloride)
Product Specifications
UNSPSC Description
Izilendustat (hydrochloride) is a potent inhibitor of prolyl hydroxylase which stabilizes hypoxia inducible factor- 1 alpha (HIF- lα), as well as hypoxia inducible factor-2 (HIF-2). Izilendustat (hydrochloride) has the potential for the research of HIF- lα related diseases including Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, anemia, colitis, and other inflammatory bowel diseases (extracted from patent WO2011057115A1/WO2011057112A1/WO2011057121A1)[1][2][3].
Target Antigen
HIF/HIF Prolyl-Hydroxylase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/izilendustat-hydrochloride.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCN(CC(C=CN2CC3=CC=C(Cl)C=C3)=C(O)C2=O)CC1)OC(C)(C)C.[H]Cl
Molecular Weight
470.39
References & Citations
[1]Joseph H, et al. Prolyl hydroxylase inhibitors. Patent WO2011057115A1. |[2]Robert Shalwitz, et al. Methods for increasing the stabilization of hypoxia inducible factor-1 alpha. Patent WO2011057112A1.|[3]Joseph H, et al. Compositions and methods for treating colitis. Patent WO2011057121A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-44809A/Izilendustat-hydrochloride-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-44809A/
Clinical Information
No Development Reported
CAS Number
1303513-80-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
38338121 3 x 1.0μg DNA
RAB3GAP2 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details TA505566S 30 µL
Tapasin Related Protein (TAPBPL) Mouse Monoclonal Antibody [Clone ID: OTI4H5]
Ask
View Details